Skip to main content
NewslettersWatchlist

Quidelortho Corp(QDEL-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low38.91
Day High40.75
Open:40.75
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
TheNewswire.com
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - QDEL
TheNewswire.com
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - QDEL
TheNewswire.com
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - QDEL
TheNewswire.com
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - QDEL
TheNewswire.com
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - QDEL
TheNewswire.com
ROSEN, A TOP RANKED LAW FIRM, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - QDEL
TheNewswire.com
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - QDEL
TheNewswire.com
ROSEN, A RANKED AND LEADING FIRM, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - QDEL
TheNewswire.com
ROSEN, LEADING INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation - QDEL
TheNewswire.com
ROSEN, A RANKED AND LEADING FIRM, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation - QDEL
TheNewswire.com
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation - QDEL
TheNewswire.com
ROSEN, A LONGSTANDING LAW FIRM, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation - QDEL
TheNewswire.com
ROSEN, A LONGSTANDING LAW FIRM, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation - QDEL
TheNewswire.com
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation - QDEL
TheNewswire.com
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation - QDEL
TheNewswire.com
ROSEN, SKILLED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation - QDEL
TheNewswire.com
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation - QDEL
TheNewswire.com
ROSEN, A LONGSTANDING LAW FIRM, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation - QDEL
TheNewswire.com
ROSEN, A TOP RANKED LAW FIRM, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation - QDEL
TheNewswire.com
QDEL LOSS ALERT: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation - QDEL
TheNewswire.com
QDEL INVESTOR ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation - QDEL
TheNewswire.com
EQUITY ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation - QDEL
TheNewswire.com
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation - QDEL
TheNewswire.com
ROSEN, NATIONAL TRIAL LAWYERS, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation - QDEL
Motley Fool
Why QuidelOrtho Stock Is Crashing Today
PR Newswire
Powerful Lyme Disease Awareness PSA Featuring Christopher Meloni Illuminates Times Square
Business Wire
QuidelOrtho Reports First Quarter 2023 Financial Results
Motley Fool
Why QuidelOrtho Stock Popped by 5% on Friday
Business Wire
QuidelOrtho Reports Preliminary Revenue Results for the First Quarter 2023
Business Wire
QuidelOrtho Announces the Formation of the International QuidelOrtho Women’s Leadership Network (QWLN)
Business Wire
QuidelOrtho Receives De Novo FDA Authorization for Sofia® 2 SARS Antigen+ FIA
Business Wire
QuidelOrtho to Participate in the Raymond James 44th Annual Institutional Investor Conference

Profile

QuidelOrtho is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The company's brand names include Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R). Its comprehensive product portfolio includes tests for a range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. QuidelOrtho, formerly known as Quidel Corporation, is based in SAN DIEGO.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.